Venus Remedies Limited
₹1,616.30
-0.49%
Delayed · cached 15 min
Fair value analysis
VENUSREM
Venus Remedies Limited
₹1,624.20
Close used for this calculation
₹2,136.96Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
70/100
Quality radar
Consensus fair value
₹2,136.96
Below FV▲ +31.6% against the close used
Model range ₹987.82 – ₹3,463.25
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹987.82Fair value₹2,136.96Bull₹3,463.25
FairClose
52-week traded range
52W low ₹431.3052W high ₹1,947.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Venus Remedies Limited closed at ₹1,624.20, 24.0% below the consensus fair value of ₹2,136.96 drawn from 9 valuation models.
Financial DNA score 70/100 — Strong. P/E of 18.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹1,760.38
+8.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹987.82
-39.2%
√(22.5 × EPS × BVPS)
EPS=76.9, BVPS=563.96 · outside Graham range (P/E 18.6, P/B 2.9) — asset-light, treat as a rough floor
Graham Formula
₹3,463.25
+113.2%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹2,745.33
+69.0%
EPS × 35.7x (sector P/E)
EPS=76.9, Sector P/E=35.7x
Peter Lynch (PEG)
₹1,922.50
+18.4%
EPS × Growth% (PEG = 1 is fair)
EPS=76.9, g=25%
EV/EBITDA
₹2,331.45
+43.5%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=1.73B
Book Value (P/B)
₹1,522.69
-6.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=563.96, ROE=16.8%, g=6%, r=10%
Reverse DCF
₹1,624.20
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7.9% | Historical: 25%
Margin of Safety
₹1,679.40
+3.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2239.2, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.